Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Delrieu, Julien"'
Autor:
Vermunt, Lisa, Muniz-Terrera, Graciela, Ter Meulen, Lea, Veal, Colin, Blennow, Kaj, Campbell, Archie, Carrié, Isabelle, Delrieu, Julien, Fauria, Karine, Huesa Rodríguez, Gema, Ingala, Silvia, Jenkins, Natalie, Molinuevo, José Luis, Ousset, Pierre-Jean, Porteous, David, Prins, Niels D., Solomon, Alina, Tom, Brian D., Zetterberg, Henrik, Zwan, Marissa, Ritchie, Craig W., Scheltens, Philip, Luscan, Gerald, Brookes, Anthony J., Visser, Pieter Jelle
Background: Recruitment is often a bottleneck in secondary prevention trials in Alzheimer disease (AD). Furthermore, screen-failure rates in these trials are typically high due to relatively low prevalence of AD pathology in individuals without demen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4a0888f38b5ffbf83dc3d9bae57389b
Autor:
Vermunt, Lisa, Muniz-Terrera, Graciela, Ter Meulen, Lea, Veal, Colin, Blennow, Kaj, Campbell, Archie, Carrié, Isabelle, Delrieu, Julien, Fauria, Karine, Huesa Rodríguez, Gema, Ingala, Silvia, Jenkins, Natalie, Molinuevo, José Luis, Ousset, Pierre-Jean, Porteous, David, Prins, Niels D., Solomon, Alina, Tom, Brian D., Zetterberg, Henrik, Zwan, Marissa, Ritchie, Craig W., Scheltens, Philip, Luscan, Gerald, Brookes, Anthony J., Visser, Pieter Jelle
Background: Recruitment is often a bottleneck in secondary prevention trials in Alzheimer disease (AD). Furthermore, screen-failure rates in these trials are typically high due to relatively low prevalence of AD pathology in individuals without demen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed383b8ec702d648054a034e110a4300